Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 1 |
2008 | 1 |
2015 | 1 |
2018 | 1 |
2019 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study.
Blood Adv. 2023 Dec 26;7(24):7494-7500. doi: 10.1182/bloodadvances.2023010943.
Blood Adv. 2023.
PMID: 37903324
Free PMC article.
Clinical Trial.
A Phosphatidylserine Source of Docosahexanoic Acid Improves Neurodevelopment and Survival of Preterm Pigs.
Buddington RK, Chizhikov VV, Iskusnykh IY, Sable HJ, Sable JJ, Holloway ZR, Blumenfeld Katzir T, van der Merwe M, Yakimkova T, Buddington KK, Lifshitz Y, Tessler S, Gilbert A.
Buddington RK, et al. Among authors: tessler s.
Nutrients. 2018 May 18;10(5):637. doi: 10.3390/nu10050637.
Nutrients. 2018.
PMID: 29783637
Free PMC article.
Item in Clipboard
Glutamate uptake is reduced in prefrontal cortex in Huntington's disease.
Hassel B, Tessler S, Faull RL, Emson PC.
Hassel B, et al. Among authors: tessler s.
Neurochem Res. 2008 Feb;33(2):232-7. doi: 10.1007/s11064-007-9463-1. Epub 2007 Aug 29.
Neurochem Res. 2008.
PMID: 17726644
Item in Clipboard
BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study.
Zuckerman T, Ram R, Akria L, Koren-Michowitz M, Hoffman R, Henig I, Lavi N, Ofran Y, Horowitz NA, Nudelman O, Tavor S, Yeganeh S, Gengrinovitch S, Flaishon L, Tessler S, Ben Yakar R, Rowe JM.
Zuckerman T, et al. Among authors: tessler s.
Blood Adv. 2019 Nov 26;3(22):3740-3749. doi: 10.1182/bloodadvances.2019000468.
Blood Adv. 2019.
PMID: 31770437
Free PMC article.
Clinical Trial.
Item in Clipboard
Impact of dosing regimen of custirsen, an antisense oligonucleotide, on safety, tolerability and cardiac repolarization in healthy subjects.
Rabinovich-Guilatt L, Elgart A, Erisson L, Willsie SK, Tessler S, Barnett-Griness O, Pande A, Spiegelstein O.
Rabinovich-Guilatt L, et al. Among authors: tessler s.
Br J Clin Pharmacol. 2015 Sep;80(3):436-45. doi: 10.1111/bcp.12633. Epub 2015 Jun 22.
Br J Clin Pharmacol. 2015.
PMID: 25782535
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite